Company Valuation: ResMed Inc.

Data adjusted to current consolidation scope
Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 30,691 32,133 28,117 37,762 28,145 31,624 - -
Change - 4.7% -12.5% 34.31% -25.47% 12.36% - -
Enterprise Value (EV) 1 31,192 33,346 28,585 37,221 27,335 30,670 29,931 29,136
Change - 6.9% -14.28% 30.21% -26.56% 12.2% -2.41% -2.65%
P/E 39.6x 35.9x 27.7x 27.1x 18.7x 18.9x 17.2x 15.8x
PBR 9.35x 7.76x 5.78x 6.33x - 4.55x 4.09x 4.19x
PEG - 2.4x 2x 0.7x 1.93x 1.6x 1.78x 1.82x
Capitalization / Revenue 8.58x 7.61x 6x 7.34x 4.98x 5.44x 5.11x 4.79x
EV / Revenue 8.72x 7.9x 6.1x 7.23x 4.84x 5.28x 4.84x 4.42x
EV / EBITDA 26.8x 25.3x 18.1x 19.8x 11.7x 13.6x 12.4x 11.3x
EV / EBIT 31.2x 27.2x 19.3x 21.1x 13.4x 14.7x 13.2x 12x
EV / FCF 144x 58.1x 22x 22.4x 16.6x 18.7x 16.9x 15.3x
FCF Yield 0.69% 1.72% 4.55% 4.46% 6.03% 5.36% 5.91% 6.54%
Dividend per Share 2 1.68 1.8 1.92 2.12 2.46 2.66 2.929 3.198
Rate of return 0.8% 0.82% 1% 0.82% 1.26% 1.21% 1.33% 1.45%
EPS 2 5.3 6.09 6.92 9.51 10.43 11.67 12.79 13.9
Distribution rate 31.7% 29.6% 27.7% 22.3% 23.6% 22.8% 22.9% 23%
Net sales 1 3,578 4,223 4,685 5,146 5,653 5,811 6,189 6,599
EBITDA 1 1,162 1,317 1,576 1,884 2,329 2,251 2,421 2,581
EBIT 1 1,000 1,224 1,478 1,763 2,039 2,092 2,262 2,421
Net income 1 779.4 897.6 1,021 1,401 1,523 1,643 1,782 1,916
Net Debt 1 501.5 1,213 468.9 -541.2 -809.9 -954.4 -1,693 -2,488
Reference price 2 209.63 218.50 191.42 258.00 194.88 219.95 219.95 219.95
Nbr of stocks (in thousands) 146,405 147,062 146,884 146,365 144,421 143,062 - -
Announcement Date 8/11/22 8/3/23 8/1/24 7/31/25 8/6/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
29.97x5.32x20.4x0.31% 223B
34.62x6.25x19.82x0.69% 144B
37.95x9.97x21.99x-.--% 124B
16.79x3.46x11.22x-.--% 65.19B
34.27x6.86x21.69x-.--% 49.99B
19.37x2.33x11.69x2.63% 50.49B
28.6x5.65x19.18x0.7% 41.4B
70.54x6.74x20.53x-.--% 39.59B
42.67x6.94x24.5x-.--% 31.87B
Average 34.98x 5.95x 19.00x 0.48% 85.5B
Weighted average by Cap. 33.13x 6.15x 19.39x 0.43%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!